upgrade to Tier 1 to access blurred content, display up to 300 records, and unlimited CSV download
Data last updated 2024-04-28 04:05:40 -0500 US CDT
Insider Sentiment
| Company Name | Sector | Industry | Shares Outstanding(Mil) | 52-week High/Low | Period | Acq/Dsp Transaction Countb | Ids/Sec/Mkt Quantc | Acq/Dsp Shares Amountb | Acq/Dsp PctSOd |
|---|---|---|---|---|---|---|---|---|---|
| Abbvie Inc. | Health Care | Pharmaceuticals | 1766.47 |
131.0
182.9
159.6
|
3-month |
0 / 11
|
|
0 / 461923
|
0.0 / 0.0 |
| 6-month |
0 / 12
|
|
0 / 464835
|
0.0 / 0.0 |
Data last updated 2024-04-27 07:55:23 -0500 US CDT
Major Shareholders
| Shareholder | Relation | Report Date | Holding Pct | Sharesa | Shares(Previous Report Date)a | Transactions (3 month)b | Transactions (6 month)b |
|---|---|---|---|---|---|---|---|
| Gonzalez Richard A | CHAIRMAN OF THE BOARD AND CEO | 2024-03-01 | 0.0% | 519099 (-32.3%, -6.0%) | 767964 (2024-02-29) |
C: 0 / 1
S: 0 / 138616 P: NA / 177.27 |
C: 0 / 1
S: 0 / 138616 P: NA / 177.27 |
| Schumacher Laura J | Vice Chairman | 2022-03-01 | 0.0% | 248002 (-13.9%, NA%) | 288492 (2022-02-22) | ||
| Saleki Gerhardt Azita | EVP, CHIEF OPERATIONS OFFICER | 2024-03-01 | 0.0% | 226173 (-9.5%, NA%) | 250139 (2024-02-23) |
C: 0 / 1
S: 0 / 52870 P: NA / 173.71 |
C: 0 / 1
S: 0 / 52870 P: NA / 173.71 |
| Chase William J | EVP, Finance & Administration | 2019-06-28 | 0.0% | 170053 (21.8%, NA%) | 139653 (2019-03-04) | ||
| Alban Carlos | Vice Chairman | 2020-11-18 | 0.0% | 155341 (0.0%, NA%) | 155341 (2020-07-08) | ||
| Severino Michael | Vice Chairman | 2022-05-25 | 0.0% | 152103 (0.0%, NA%) | 152103 (2022-05-18) | ||
| Gosebruch Henry O | EVP, Chief Strategy Officer | 2022-05-20 | 0.0% | 143841 (45.9%, NA%) | 98580 (2022-05-18) | ||
| Freyman Thomas C | Director | 2023-05-09 | 0.0% | 132108 (1.1%, NA%) | 130658 (2022-05-09) | ||
| Hudson Thomas J | SVP, CSO, GLOBAL RESEARCH | 2024-03-01 | 0.0% | 107267 (-16.0%, NA%) | 127901 (2024-02-20) | ||
| Michael Robert A. | PRES & CHIEF OPERATING OFFICER | 2024-03-01 | 0.0% | 98645 (-46.2%, NA%) | 183602 (2024-02-20) |
C: 0 / 1
S: 0 / 68879 P: NA / 176.45 |
C: 0 / 1
S: 0 / 68879 P: NA / 176.45 |
| Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | 2024-03-22 | 0.0% | 55903 (-27.3%, 0.0%) | 76985 (2024-03-01) |
C: 0 / 1
S: 0 / 21082 P: NA / 176.3 |
C: 0 / 2
S: 0 / 23994 P: NA / 173.68 |
| Tilton Glenn F | Director | 2023-05-09 | 0.0% | 49389 (3.0%, NA%) | 47939 (2022-05-09) | ||
| Rapp Edward J | Director | 2023-05-09 | 0.0% | 40422 (3.7%, NA%) | 38972 (2022-05-09) | ||
| Austin Roxanne S | Director | 2023-05-09 | 0.0% | 35933 (-11.6%, NA%) | 40705 (2023-02-21) | ||
| Alpern Robert J | Director | 2023-09-11 | 0.0% | 33121 (0.4%, NA%) | 32992 (2023-05-09) | ||
| Strom Carrie C | SVP & PRES GLOBAL ALLERG AESTH | 2023-05-12 | 0.0% | 28024 (-9.2%, NA%) | 30900 (2023-03-07) | ||
| Waddell Frederick H | Director | 2023-05-09 | 0.0% | 26433 (5.8%, NA%) | 24983 (2022-05-09) | ||
| Thakkar Roopal | SVP, CMO, GLOBAL THERAPEUTICS | 2024-03-01 | 0.0% | 23259 (-17.3%, -22.9%) | 28173 (2024-02-20) |
a Total of direct and indirect accounts with percentage change comparing with (previous report, 3 months ago). The latter is NA when no change was found in the last 3 months.
Notice: Shares amount and percentage change 1) do not reflect intraday conversion and execution of derivative securities. 2) may subject to correction on amendment filing.
b Vital&Spontaneous transactions of the past 3 and 6 months, respectively. For acquisitions, code P (open market purchase), L (small acquisition), and I (at discretion of broker) are counted. For dispositions, code S (open market sell), D (sell back to issuer) and I (at discretion of broker) are counted. "C:" count of number of transactions. "S:" shares amount involved in corrresponding transactions. "P:" average per share price of the transactions (for reference only). Horizontal bar chart denotes shares amount of acquisitions and dispositions. Black thin bar is fixed size ruler for easy comparison between reporters.
c Quantile value of transaction count in b among industry peers, sector peers, and the market, respectively.
d Percentage of transaction shares amount to shares outstanding.
Notice: red exclamation mark (!) represents the reporter has Form 4 amendment filings in the latest three reports.
Non-derivative Transactions Chart
Tips: Click legend to show single series Click any bar to highlight corresponding transaction records
what is this?
Non-derivative Transactions Table
CSV download
Tips: Click legend to show single series Click any bar to highlight corresponding transaction records what is this?
|
|
|
Tips: type "code_p" to show transactions with code "P".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-22 | 2024-03-20 | 2024-03-20 | 4 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | dsp | 21082.0 | 27.38 | 0.12 | 176.3 | Direct | Common Stock | ABBVIE INC. | code S | 55903.0 | 1766.47 (ABBV) |
| 2024-03-20 | 2024-03-18 | 4 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | holding | 1338.0 | 0 | 0.01 | 0.0 | By Spouse In Trust | Common Stock | ABBVIE INC. | NA | 1766.47 (ABBV) | ||
| 2024-03-20 | 2024-03-18 | 2024-03-18 | 4 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | dsp | 58949.0 | 49.17 | 0.33 | 178.79 | Direct | Common Stock | ABBVIE INC. | code S | 60941.0
|
1766.47 (ABBV) |
| 2024-03-20 | 2024-03-18 | 2024-03-18 | 4 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | acq | 26110.0 | 21.78 | 0.15 | 61.36 | Direct | Common Stock | ABBVIE INC. | code M | 119890.0 | 1766.47 (ABBV) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Richmond Timothy J. | EVP, CHIEF HR OFFICER | dsp | 75680.0 | 84.54 | 0.43 | 177.27 | Direct | Common Stock | ABBVIE INC. | code S | 13837.0
|
1766.47 (ABBV) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Richmond Timothy J. | EVP, CHIEF HR OFFICER | acq | 45700.0 | 51.05 | 0.26 | 61.36 | Direct | Common Stock | ABBVIE INC. | code M | 89517.0 | 1766.47 (ABBV) |
| 2024-03-01 | 2024-02-28 | 2024-02-28 to 2024-02-29 | 4 | Buckbee Kevin K | SVP, CONTROLLER | dsp | 10483.0 | 60.02 | 0.06 | 177.84 | Direct | Common Stock | ABBVIE INC. | code F S | 6983.0
|
1766.47 (ABBV) |
| 2024-03-01 | 2024-02-28 | 2024-02-28 | 4 | Gonzalez Richard A | CHAIRMAN OF THE BOARD AND CEO | dsp | 248865.0 | 32.41 | 1.41 | 178.03 | Direct | Common Stock | ABBVIE INC. | code F S | 519099.0
|
1766.47 (ABBV) |
| 2024-03-01 | 2024-02-28 | 2024-02-28 | 4 | Saleki Gerhardt Azita | EVP, CHIEF OPERATIONS OFFICER | dsp | 23966.0 | 9.82 | 0.14 | 178.99 | Direct | Common Stock | ABBVIE INC. | code F | 219978.0 | 1766.47 (ABBV) |
| 2024-03-01 | 2024-02-28 | 4 | Saleki Gerhardt Azita | EVP, CHIEF OPERATIONS OFFICER | holding | 2322.0 | 0 | 0.01 | 0.0 | Profit Sharing Trust | Common Stock | ABBVIE INC. | NA | 1766.47 (ABBV) | ||
| 2024-03-01 | 2024-02-28 | 4 | Saleki Gerhardt Azita | EVP, CHIEF OPERATIONS OFFICER | holding | 3873.0 | 0 | 0.02 | 0.0 | By Spouse | Common Stock | ABBVIE INC. | NA | 1766.47 (ABBV) | ||
| 2024-03-01 | 2024-02-28 | 2024-02-28 | 4 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | dsp | 16771.0 | 17.89 | 0.09 | 178.99 | Direct | Common Stock | ABBVIE INC. | code F | 76985.0 | 1766.47 (ABBV) |
| 2024-03-01 | 2024-02-28 | 2024-02-28 | 4 | Richmond Timothy J. | EVP, CHIEF HR OFFICER | dsp | 23847.0 | 35.24 | 0.13 | 178.99 | Direct | Common Stock | ABBVIE INC. | code F | 43817.0 | 1766.47 (ABBV) |
| 2024-03-01 | 2024-02-28 | 2024-02-28 to 2024-02-29 | 4 | Siatis Perry C | EVP, GC AND SECRETARY | dsp | 17776.0 | 63.1 | 0.1 | 178.1 | Direct | Common Stock | ABBVIE INC. | code F S | 10397.0
|
1766.47 (ABBV) |
| 2024-03-01 | 2024-02-28 | 2024-02-28 | 4 | Hudson Thomas J | SVP, CSO, GLOBAL RESEARCH | dsp | 20634.0 | 16.13 | 0.12 | 178.99 | Direct | Common Stock | ABBVIE INC. | code F | 107267.0 | 1766.47 (ABBV) |
| 2024-03-01 | 2024-02-23 | 2024-02-23 to 2024-02-28 | 4 | Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | dsp | 25774.0 | 62.55 | 0.15 | 178.14 | Direct | Common Stock | ABBVIE INC. | code F S | 15431.0
|
1766.47 (ABBV) |
| 2024-03-01 | 2024-02-23 | 2024-02-23 | 4 | Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | acq | 14140.0 | 34.32 | 0.08 | 61.36 | Direct | Common Stock | ABBVIE INC. | code M | 41205.0 | 1766.47 (ABBV) |
| 2024-03-01 | 2024-02-28 | 2024-02-28 | 4 | Thakkar Roopal | SVP, CMO, GLOBAL THERAPEUTICS | dsp | 4914.0 | 17.44 | 0.03 | 178.99 | Direct | Common Stock | ABBVIE INC. | code F | 23259.0 | 1766.47 (ABBV) |
| 2024-03-01 | 2024-02-28 | 2024-02-28 | 4 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | dsp | 26121.0 | 21.79 | 0.15 | 178.99 | Direct | Common Stock | ABBVIE INC. | code F | 93780.0 | 1766.47 (ABBV) |
| 2024-03-01 | 2024-02-28 | 4 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | holding | 1338.0 | 0 | 0.01 | 0.0 | By Spouse In Trust | Common Stock | ABBVIE INC. | NA | 1766.47 (ABBV) | ||
| 2024-03-01 | 2024-02-28 | 2024-02-29 | 4 | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | acq | 21560.0 | 12.87 | 0.12 | 58.3 | Direct | Common Stock | ABBVIE INC. | code M | 167524.0
|
1766.47 (ABBV) |
| 2024-03-01 | 2024-02-28 | 2024-02-28 to 2024-02-29 | 4 | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | dsp | 106517.0 | 51.92 | 0.6 | 177.35 | Direct | Common Stock | ABBVIE INC. | code F S | 98645.0
|
1766.47 (ABBV) |
| 2024-02-29 | 2024-02-27 | 2024-02-27 | 4 | Gonzalez Richard A | CHAIRMAN OF THE BOARD AND CEO | dsp | 4195.0 | 0.54 | 0.02 | 0.0 | Direct | Common Stock | ABBVIE INC. | code G | 767964.0
|
1766.47 (ABBV) |
| 2024-02-27 | 2024-02-23 | 2024-02-23 | 4 | Siatis Perry C | EVP, GC AND SECRETARY | acq | 13753.0 | 32.8 | 0.08 | 137.36 | Direct | Common Stock | ABBVIE INC. | code M | 41926.0
|
1766.47 (ABBV) |
| 2024-02-27 | 2024-02-23 | 2024-02-23 | 4 | Siatis Perry C | EVP, GC AND SECRETARY | dsp | 13753.0 | 32.8 | 0.08 | 177.51 | Direct | Common Stock | ABBVIE INC. | code S | 28173.0 | 1766.47 (ABBV) |
| 2024-02-23 | 2024-02-21 | 2024-02-21 | 4 | Saleki Gerhardt Azita | EVP, CHIEF OPERATIONS OFFICER | acq | 52870.0 | 17.81 | 0.3 | 58.88 | Direct | Common Stock | ABBVIE INC. | code M | 296814.0 | 1766.47 (ABBV) |
| 2024-02-23 | 2024-02-21 | 2024-02-21 | 4 | Saleki Gerhardt Azita | EVP, CHIEF OPERATIONS OFFICER | dsp | 52870.0 | 17.81 | 0.3 | 173.71 | Direct | Common Stock | ABBVIE INC. | code S | 243944.0 | 1766.47 (ABBV) |
| 2024-02-23 | 2024-02-21 | 4 | Saleki Gerhardt Azita | EVP, CHIEF OPERATIONS OFFICER | holding | 2322.0 | 0 | 0.01 | 0.0 | Profit Sharing Trust | Common Stock | ABBVIE INC. | NA | 1766.47 (ABBV) | ||
| 2024-02-23 | 2024-02-21 | 4 | Saleki Gerhardt Azita | EVP, CHIEF OPERATIONS OFFICER | holding | 3873.0 | 0 | 0.02 | 0.0 | By Spouse | Common Stock | ABBVIE INC. | NA | 1766.47 (ABBV) | ||
| 2024-02-20 | 2024-02-15 | 2024-02-15 | 4 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | acq | 37853.0 | 40.37 | 0.21 | 0.0 | Direct | Common Stock | ABBVIE INC. | code A | 93756.0
|
1765.54 (ABBV) |
Derivative Transactions Chart
Tips: Click legend to show single series Click any bar to highlight corresponding transaction records
what is this?
Derivative Transactions Table
Tips: Click legend to show single series Click any bar to highlight corresponding transaction records what is this?
|
|
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-02 | 2024-03-31 | 2024-03-31 | 4 | Alpern Robert J | DIRECTOR | acq | 41.0 | 0.44 | 0.0 | 182.1 | Direct | Stock Equivalent Units | ABBVIE INC. | code A | 9408.0 | 1766.47 (ABBV) |
| 2024-04-02 | 2024-03-31 | 2024-03-31 | 4 | Rapp Edward J | DIRECTOR | acq | 212.0 | 0.82 | 0.0 | 182.1 | Direct | Stock Equivalent Units | ABBVIE INC. | code A | 25701.0 | 1766.47 (ABBV) |
| 2024-04-02 | 2024-03-31 | 2024-03-31 | 4 | Quaggin Susan E | DIRECTOR | acq | 82.0 | 55.78 | 0.0 | 182.1 | Direct | Stock Equivalent Units | ABBVIE INC. | code A | 147.0 | 1766.47 (ABBV) |
| 2024-03-20 | 2024-03-18 | 2024-03-18 | 4 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | dsp | 26110.0 | 100.0 | 0.15 | 61.36 | Direct | Option (Right To Buy) | ABBVIE INC. | code M | 0.0 | 1766.47 (ABBV) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Richmond Timothy J. | EVP, CHIEF HR OFFICER | dsp | 45700.0 | 100.0 | 0.26 | 61.36 | Direct | Option (Right To Buy) | ABBVIE INC. | code M | 0.0 | 1766.47 (ABBV) |
| 2024-03-01 | 2024-02-23 | 2024-02-23 | 4 | Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | dsp | 14140.0 | 44.86 | 0.08 | 61.36 | Direct | Option (Right To Buy) | ABBVIE INC. | code M | 17380.0 | 1766.47 (ABBV) |
| 2024-03-01 | 2024-02-28 | 2024-02-29 | 4 | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | dsp | 21560.0 | 100.0 | 0.12 | 58.3 | Direct | Option (Right To Buy) | ABBVIE INC. | code M | 0.0
|
1766.47 (ABBV) |
| 2024-02-27 | 2024-02-23 | 2024-02-23 | 4 | Siatis Perry C | EVP, GC AND SECRETARY | acq | 13753.0 | 94.01 | 0.08 | 137.36 | Direct | Option (Right To Buy) | ABBVIE INC. | code M | 14629.0
|
1766.47 (ABBV) |
| 2024-02-23 | 2024-02-21 | 2024-02-21 | 4 | Saleki Gerhardt Azita | EVP, CHIEF OPERATIONS OFFICER | dsp | 52870.0 | 100.0 | 0.3 | 58.88 | Direct | Option (Right To Buy) | ABBVIE INC. | code M | 0.0 | 1766.47 (ABBV) |
| 2024-02-20 | 2024-02-15 | 2024-02-15 | 4 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | acq | 21433.0 | 100.0 | 0.12 | 0.0 | Direct | Option (Right To Buy) | ABBVIE INC. | code A | 21433.0 | 1765.54 (ABBV) |
| 2024-02-20 | 2024-02-15 | 2024-02-15 | 4 | Gonzalez Richard A | CHAIRMAN OF THE BOARD AND CEO | acq | 113472.0 | 100.0 | 0.64 | 0.0 | Direct | Option (Right To Buy) | ABBVIE INC. | code A | 113472.0 | 1765.54 (ABBV) |
| 2024-02-20 | 2024-02-15 | 2024-02-15 | 4 | Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | acq | 31520.0 | 100.0 | 0.18 | 0.0 | Direct | Option (Right To Buy) | ABBVIE INC. | code A | 31520.0 | 1765.54 (ABBV) |
| 2024-02-20 | 2024-02-15 | 2024-02-15 | 4 | Michael Robert A. | PRES & CHIEF OPERATING OFFICER | acq | 59888.0 | 100.0 | 0.34 | 0.0 | Direct | Option (Right To Buy) | ABBVIE INC. | code A | 59888.0 | 1765.54 (ABBV) |
| 2024-02-20 | 2024-02-15 | 2024-02-15 | 4 | Buckbee Kevin K | SVP, CONTROLLER | acq | 6934.0 | 100.0 | 0.04 | 0.0 | Direct | Option (Right To Buy) | ABBVIE INC. | code A | 6934.0 | 1765.54 (ABBV) |
| 2024-02-20 | 2024-02-15 | 2024-02-15 | 4 | Hudson Thomas J | SVP, CSO, GLOBAL RESEARCH | acq | 18912.0 | 100.0 | 0.11 | 0.0 | Direct | Option (Right To Buy) | ABBVIE INC. | code A | 18912.0 | 1765.54 (ABBV) |
| 2024-02-20 | 2024-02-15 | 2024-02-15 | 4 | Siatis Perry C | EVP, GC AND SECRETARY | acq | 23324.0 | 100.0 | 0.13 | 0.0 | Direct | Option (Right To Buy) | ABBVIE INC. | code A | 23324.0 | 1765.54 (ABBV) |
| 2024-02-20 | 2024-02-15 | 2024-02-15 | 4 | Richmond Timothy J. | EVP, CHIEF HR OFFICER | acq | 28998.0 | 100.0 | 0.16 | 0.0 | Direct | Option (Right To Buy) | ABBVIE INC. | code A | 28998.0 | 1765.54 (ABBV) |
| 2024-02-20 | 2024-02-15 | 2024-02-15 | 4 | Thakkar Roopal | SVP, CMO, GLOBAL THERAPEUTICS | acq | 13868.0 | 100.0 | 0.08 | 0.0 | Direct | Option (Right To Buy) | ABBVIE INC. | code A | 13868.0 | 1765.54 (ABBV) |
| 2024-02-20 | 2024-02-15 | 2024-02-15 | 4 | Saleki Gerhardt Azita | EVP, CHIEF OPERATIONS OFFICER | acq | 29313.0 | 100.0 | 0.17 | 0.0 | Direct | Option (Right To Buy) | ABBVIE INC. | code A | 29313.0 | 1765.54 (ABBV) |
| 2024-02-20 | 2024-02-15 | 2024-02-15 | 4 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | acq | 39085.0 | 100.0 | 0.22 | 0.0 | Direct | Option (Right To Buy) | ABBVIE INC. | code A | 39085.0 | 1765.54 (ABBV) |
| 2024-02-06 | 2024-02-02 | 2024-02-02 | 4 | Siatis Perry C | EVP, GC AND SECRETARY | dsp | 2919.0 | 33.34 | 0.02 | 144.54 | Direct | Option (Right To Buy) | ABBVIE INC. | code M | 5837.0 | 1765.54 (ABBV) |
| 2024-01-03 | 2023-12-31 | 2023-12-31 | 4 | Rapp Edward J | DIRECTOR | acq | 250.0 | 0.99 | 0.0 | 154.97 | Direct | Stock Equivalent Units | ABBVIE INC. | code A | 25266.0 | 1765.54 (ABBV) |
| 2024-01-03 | 2023-12-31 | 2023-12-31 | 4 | Alpern Robert J | DIRECTOR | acq | 48.0 | 0.52 | 0.0 | 154.97 | Direct | Stock Equivalent Units | ABBVIE INC. | code A | 9285.0 | 1765.54 (ABBV) |
| 2024-01-03 | 2023-12-31 | 2023-12-31 | 4 | Quaggin Susan E | DIRECTOR | acq | 64.0 | 100.0 | 0.0 | 154.97 | Direct | Stock Equivalent Units | ABBVIE INC. | code A | 64.0 | 1765.54 (ABBV) |
Form 3 CSV download
| Filing Date | Date requiring statement | Form Type | Reporter | Relation | Amounta | ‱(SO)c | Avg Excercisable Prcd | Account | Type | Full Name | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-22 | 2023-12-14 | 3 | THAKKAR ROOPAL | SVP, Global Therapeutics & CMO | 30225.0 | 0.17 | 0.0 | Direct | common stock | ABBVIE INC. | 1765.54 (ABBV) |
| 2023-12-22 | 2023-12-14 | 3 | THAKKAR ROOPAL | SVP, Global Therapeutics & CMO | 40873.0
|
0.23 | 115.73 | Direct | option (right to buy) | ABBVIE INC. | 1765.54 (ABBV) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to 30 records per table for current tier. (Access Guide)